199 related articles for article (PubMed ID: 31737572)
1. Multi-platform Affinity Proteomics Identify Proteins Linked to Metastasis and Immune Suppression in Ovarian Cancer Plasma.
Graumann J; Finkernagel F; Reinartz S; Stief T; Brödje D; Renz H; Jansen JM; Wagner U; Worzfeld T; Pogge von Strandmann E; Müller R
Front Oncol; 2019; 9():1150. PubMed ID: 31737572
[TBL] [Abstract][Full Text] [Related]
2. Dual-platform affinity proteomics identifies links between the recurrence of ovarian carcinoma and proteins released into the tumor microenvironment.
Finkernagel F; Reinartz S; Schuldner M; Malz A; Jansen JM; Wagner U; Worzfeld T; Graumann J; von Strandmann EP; Müller R
Theranostics; 2019; 9(22):6601-6617. PubMed ID: 31588238
[TBL] [Abstract][Full Text] [Related]
3. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
[No Abstract] [Full Text] [Related]
4. Sample-Treatment with the Virucidal β-Propiolactone Does Not Preclude Analysis by Large Panel Affinity Proteomics, Including the Discovery of Biomarker Candidates.
Beutgen VM; Bhagwat AM; Steitz AM; Reinartz S; Müller R; Graumann J
Anal Chem; 2024 Jun; 96(23):9332-9342. PubMed ID: 38810147
[TBL] [Abstract][Full Text] [Related]
5. Complementarity of SOMAscan to LC-MS/MS and RNA-seq for quantitative profiling of human embryonic and mesenchymal stem cells.
Billing AM; Ben Hamidane H; Bhagwat AM; Cotton RJ; Dib SS; Kumar P; Hayat S; Goswami N; Suhre K; Rafii A; Graumann J
J Proteomics; 2017 Jan; 150():86-97. PubMed ID: 27613379
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of neurotensin in high grade serous ovarian carcinoma with evidence of serous tubal intraepithelial carcinoma.
Norris EJ; Zhang Q; Jones WD; DeStephanis D; Sutker AP; Livasy CA; Ganapathi RN; Tait DL; Ganapathi MK
J Pathol; 2019 Jul; 248(3):352-362. PubMed ID: 30883751
[TBL] [Abstract][Full Text] [Related]
7. Profile of differentially expressed miRNAs in high-grade serous carcinoma and clear cell ovarian carcinoma, and the expression of miR-510 in ovarian carcinoma.
Zhang X; Guo G; Wang G; Zhao J; Wang B; Yu X; Ding Y
Mol Med Rep; 2015 Dec; 12(6):8021-31. PubMed ID: 26497752
[TBL] [Abstract][Full Text] [Related]
8. N-Glycoproteomics of Patient-Derived Xenografts: A Strategy to Discover Tumor-Associated Proteins in High-Grade Serous Ovarian Cancer.
Sinha A; Hussain A; Ignatchenko V; Ignatchenko A; Tang KH; Ho VWH; Neel BG; Clarke B; Bernardini MQ; Ailles L; Kislinger T
Cell Syst; 2019 Apr; 8(4):345-351.e4. PubMed ID: 30981729
[TBL] [Abstract][Full Text] [Related]
9. Combination of TP53 and AGR3 to distinguish ovarian high-grade serous carcinoma from low-grade serous carcinoma.
Qiu C; Wang Y; Wang X; Zhang Q; Li Y; Xu Y; Jin C; Bu H; Zheng W; Yang X; Lu N; Kong B
Int J Oncol; 2018 Jun; 52(6):2041-2050. PubMed ID: 29620196
[TBL] [Abstract][Full Text] [Related]
10. Low levels of IGFBP7 expression in high-grade serous ovarian carcinoma is associated with patient outcome.
Gambaro K; Quinn MC; Cáceres-Gorriti KY; Shapiro RS; Provencher D; Rahimi K; Mes-Masson AM; Tonin PN
BMC Cancer; 2015 Mar; 15():135. PubMed ID: 25886299
[TBL] [Abstract][Full Text] [Related]
11. Proteomics-Derived Biomarker Panel Improves Diagnostic Precision to Classify Endometrioid and High-grade Serous Ovarian Carcinoma.
Dieters-Castator DZ; Rambau PF; Kelemen LE; Siegers GM; Lajoie GA; Postovit LM; Köbel M
Clin Cancer Res; 2019 Jul; 25(14):4309-4319. PubMed ID: 30979743
[TBL] [Abstract][Full Text] [Related]
12. Validation of a Novel Modified Aptamer-Based Array Proteomic Platform in Patients with End-Stage Renal Disease.
Han Z; Xiao Z; Kalantar-Zadeh K; Moradi H; Shafi T; Waikar SS; Quarles LD; Yu Z; Tin A; Coresh J; Kovesdy CP
Diagnostics (Basel); 2018 Oct; 8(4):. PubMed ID: 30297602
[TBL] [Abstract][Full Text] [Related]
13. A distinct pre-existing inflammatory tumour microenvironment is associated with chemotherapy resistance in high-grade serous epithelial ovarian cancer.
Koti M; Siu A; Clément I; Bidarimath M; Turashvili G; Edwards A; Rahimi K; Mes-Masson AM; Squire JA
Br J Cancer; 2015 Mar; 112(7):1215-22. PubMed ID: 25826225
[TBL] [Abstract][Full Text] [Related]
14. Expression of serum human epididymal secretory protein E4 at low grade and high grade serous carcinomas.
Zhu YF; He LS; Zhang ZD; Huang QS
Asian Pac J Trop Med; 2012 Dec; 5(12):925-30. PubMed ID: 23199707
[TBL] [Abstract][Full Text] [Related]
15. Primary and recurrent ovarian high-grade serous carcinomas display similar microRNA expression patterns relative to those of normal ovarian tissue.
Nam EJ; Kim S; Lee TS; Kim HJ; Lee JY; Kim SW; Kim JH; Kim YT
Oncotarget; 2016 Oct; 7(43):70524-70534. PubMed ID: 27655640
[TBL] [Abstract][Full Text] [Related]
16. CD105 Is Expressed in Ovarian Cancer Precursor Lesions and Is Required for Metastasis to the Ovary.
Bai S; Zhu W; Coffman L; Vlad A; Schwartz LE; Elishaev E; Drapkin R; Buckanovich RJ
Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31684072
[No Abstract] [Full Text] [Related]
17. Proteomic study of hepatocellular carcinoma using a novel modified aptamer-based array (SOMAscan™) platform.
Qiao Z; Pan X; Parlayan C; Ojima H; Kondo T
Biochim Biophys Acta Proteins Proteom; 2017 Apr; 1865(4):434-443. PubMed ID: 27663888
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Proteomic Measurements Across Platforms in the Atherosclerosis Risk in Communities (ARIC) Study.
Rooney MR; Chen J; Ballantyne CM; Hoogeveen RC; Tang O; Grams ME; Tin A; Ndumele CE; Zannad F; Couper DJ; Tang W; Selvin E; Coresh J
Clin Chem; 2023 Jan; 69(1):68-79. PubMed ID: 36508319
[TBL] [Abstract][Full Text] [Related]
19. An integrated proteomic and glycoproteomic approach uncovers differences in glycosylation occupancy from benign and malignant epithelial ovarian tumors.
Li QK; Shah P; Tian Y; Hu Y; Roden RBS; Zhang H; Chan DW
Clin Proteomics; 2017; 14():16. PubMed ID: 28491011
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic inactivation of SPINT2 is associated with tumor suppressive function in esophageal squamous cell carcinoma.
Yue D; Fan Q; Chen X; Li F; Wang L; Huang L; Dong W; Chen X; Zhang Z; Liu J; Wang F; Wang M; Zhang B; Zhang Y
Exp Cell Res; 2014 Mar; 322(1):149-58. PubMed ID: 24269829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
